These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


70 related items for PubMed ID: 687391

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacologic investigation of compounds related to 3,4-methylenedioxyamphetamine (MDA).
    Davis WM, Borne RF.
    Subst Alcohol Actions Misuse; 1984; 5(2):105-10. PubMed ID: 6147902
    [Abstract] [Full Text] [Related]

  • 3. The protective effects of methysergide, 6-hydroxydopamine and other agents on the toxicity of amphetamine, phentermine, MDA, PMA, and STP in mice.
    Lopatka JE, Brewerton CN, Brooks DS, Cook DA, Paton DM.
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):677-87. PubMed ID: 989173
    [Abstract] [Full Text] [Related]

  • 4. Triphasic dose-lethality relationships for amphetamine and certain ring-substituted amphetamines in isolated or aggregated mice.
    Davis WM, Waters IW, Hatoum HT, Buelke JL, Braude MC.
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):575-82. PubMed ID: 578333
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of DA in the stimulant effect of DITA in mice; comparison with d-amphetamine.
    Abdallah AH, Roby DM, Boeckler WH, Riley CC.
    Eur J Pharmacol; 1976 Jan; 35(1):29-34. PubMed ID: 1253826
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological evidence for the central serotonergic effects of monomethoxyamphetamines.
    Menon MK, Tseng LF, Loh HH.
    J Pharmacol Exp Ther; 1976 May; 197(2):272-9. PubMed ID: 946817
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fluorescence polarization immunoassay detection of amphetamine, methamphetamine, and illicit amphetamine analogues.
    Cody JT, Schwarzhoff R.
    J Anal Toxicol; 1993 May; 17(1):23-33. PubMed ID: 8429622
    [Abstract] [Full Text] [Related]

  • 10. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB, Ho BT.
    Psychopharmacology (Berl); 1980 May; 68(3):209-15. PubMed ID: 6771804
    [Abstract] [Full Text] [Related]

  • 11. Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine.
    Hutchins DA, Rogers KJ.
    Br J Pharmacol; 1971 Nov; 43(3):504-13. PubMed ID: 4400527
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF, Loh HH.
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract] [Full Text] [Related]

  • 14. Catecholaminergic influences on induced hippocampal paroxysmal activity in rats.
    de Campos CJ, Cavalheiro EA.
    Acta Physiol Pharmacol Latinoam; 1986 Jun; 36(3):233-49. PubMed ID: 3577804
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cross-reactivity of amphetamine analogues with Roche Abuscreen radioimmunoassay reagents.
    Cody JT.
    J Anal Toxicol; 1990 Jun; 14(1):50-3. PubMed ID: 2314063
    [Abstract] [Full Text] [Related]

  • 17. Relative role of catecholamines in head-shaking of infant rats.
    Holmgren B, Urbá-Holmgren R, Valdés M.
    Pharmacol Biochem Behav; 1976 Jul; 5(1):29-34. PubMed ID: 1033563
    [Abstract] [Full Text] [Related]

  • 18. Memory facilitation by naloxone is due to release of dopaminergic and beta-adrenergic systems from tonic inhibition.
    Izquierdo I, Graudenz M.
    Psychopharmacology (Berl); 1980 Jul; 67(3):265-8. PubMed ID: 6247739
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.